Literature DB >> 19776660

Differential contractile impairment of fast- and slow-twitch skeletal muscles in a rat model of doxorubicin-induced congestive heart failure.

Mert Ertunc1, Yildirim Sara, Petek Korkusuz, Rustu Onur.   

Abstract

Congestive heart failure (CHF) is associated with exercise intolerance that cannot be entirely explained by hypoperfusion of the skeletal muscles. We studied the contractile properties of fast-twitch (extensor digitorum longus; EDL) and slow-twitch (soleus; SOL) skeletal muscles in doxorubicin-induced CHF in rats, and evaluated the defective steps of excitation-contraction coupling. Both types of muscles-obtained from CHF rats displayed significant reduction in twitch and tetanic contractions. Twitch half-relaxation times of CHF SOL muscles were prolonged while there was no significant difference in EDL muscles. High K(+) application induced lower contracture amplitudes in CHF muscles. Caffeine-induced contractures were significantly diminished in CHF SOL. Verapamil application depressed tetanic contractions in all preparations while depression was more pronounced in CHF SOL. Immunohistochemistry revealed reduced expression of sarcoplasmic reticulum Ca(2+)-ATPase-1 and -2 in CHF EDL and in CHF SOL, respectively. Sarcolemmal excitability and spontaneous neurotransmitter release were unaffected since resting membrane potential, action potential and miniature end-plate potentials were unaltered in CHF muscles. We conclude that CHF induces contractile impairment that occurs predominantly in rat slow-twitch skeletal muscles. Our results suggest that this muscle-type-specific effect of CHF is related to the defective intracellular Ca(2+) release and uptake mechanisms and reduced sarcolemmal-dihydropyridine-sensitive Ca(2+) channel activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776660     DOI: 10.1159/000241723

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  12 in total

1.  The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle.

Authors:  Laura A A Gilliam; Kelsey H Fisher-Wellman; Chien-Te Lin; Jill M Maples; Brook L Cathey; P Darrell Neufer
Journal:  Free Radic Biol Med       Date:  2013-09-07       Impact factor: 7.376

Review 2.  Endurance exercise protects skeletal muscle against both doxorubicin-induced and inactivity-induced muscle wasting.

Authors:  Scott K Powers; Jose A Duarte; Branden Le Nguyen; Hayden Hyatt
Journal:  Pflugers Arch       Date:  2018-11-13       Impact factor: 3.657

3.  Exercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle.

Authors:  Ashley J Smuder; Andreas N Kavazis; Kisuk Min; Scott K Powers
Journal:  J Appl Physiol (1985)       Date:  2011-02-10

4.  Effects of chronic heart failure on neuronal nitric oxide synthase-mediated control of microvascular O2 pressure in contracting rat skeletal muscle.

Authors:  Steven W Copp; Daniel M Hirai; Scott K Ferguson; Clark T Holdsworth; Timothy I Musch; David C Poole
Journal:  J Physiol       Date:  2012-06-11       Impact factor: 5.182

Review 5.  Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.

Authors:  Laura A A Gilliam; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2011-06-15       Impact factor: 8.401

6.  Differential morphofunctional characteristics and gene expression in fast and slow muscle of rats with monocrotaline-induced heart failure.

Authors:  Raquel Santilone Bertaglia; Joyce Reissler; Francis Silva Lopes; Walter Luiz Garrido Cavalcante; Fernanda Regina Carani; Carlos Roberto Padovani; Sergio Augusto Rodrigues; Antônio Carlos Cigogna; Robson Francisco Carvalho; Ana Angélica Henrique Fernandes; Marcia Gallacci; Maeli Dal Pai Silva
Journal:  J Mol Histol       Date:  2011-04-21       Impact factor: 2.611

7.  Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle.

Authors:  Andreas N Kavazis; Ashley J Smuder; Scott K Powers
Journal:  J Appl Physiol (1985)       Date:  2014-06-19

8.  Modification of Neuromuscular Junction Protein Expression by Exercise and Doxorubicin.

Authors:  Andres Mor Huertas; Aaron B Morton; J Matthew Hinkey; Noriko Ichinoseki-Sekine; Ashley J Smuder
Journal:  Med Sci Sports Exerc       Date:  2020-07

9.  Docetaxel does not impair skeletal muscle force production in a murine model of cancer chemotherapy.

Authors:  Thomas Chaillou; Ashley McPeek; Johanna T Lanner
Journal:  Physiol Rep       Date:  2017-06

10.  Effects of endurance exercise and doxorubicin on skeletal muscle myogenic regulatory factor expression.

Authors:  Colin J Quinn; David S Hydock
Journal:  Muscles Ligaments Tendons J       Date:  2018-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.